tiprankstipranks
Ascendis Pharma (ASND)
NASDAQ:ASND
US Market
ASND
Ascendis Pharma
RESEARCH TOOLSreports

Ascendis Pharma (ASND) Stock News & Sentiment

698 Followers
Ascendis Pharma Reports Strong Week 52 COACH Trial Data for TransCon CNP and hGH Combo in Achondroplasia
Premium
Company Announcements
Ascendis Pharma Reports Strong Week 52 COACH Trial Data for TransCon CNP and hGH Combo in Achondroplasia
6d ago
6K
ASND
Ascendis Pharma to Replace ADSs With Direct Ordinary Share Listing on Nasdaq
Premium
Company Announcements
Ascendis Pharma to Replace ADSs With Direct Ordinary Share Listing on Nasdaq
6d ago
6K
ASND
Ascendis Pharma Secures U.S. Orphan Drug Exclusivity and Launches YUVIWEL for Achondroplasia
Premium
Company Announcements
Ascendis Pharma Secures U.S. Orphan Drug Exclusivity and Launches YUVIWEL for Achondroplasia
8d ago
6K
ASND
Ascendis Pharma Expands Share Capital Following March 30 Warrant Exercises
Premium
Company Announcements
Ascendis Pharma Expands Share Capital Following March 30 Warrant Exercises
15d ago
6K
ASND
Ascendis Pharma Shareholders Back Board, Loss Carryforward and New Buyback Mandate at 2026 AGM
Premium
Company Announcements
Ascendis Pharma Shareholders Back Board, Loss Carryforward and New Buyback Mandate at 2026 AGM
21d ago
6K
ASND
Ascendis Pharma Posts Positive Phase 2 Results for Once-Weekly TransCon hGH in Turner Syndrome
Premium
Company Announcements
Ascendis Pharma Posts Positive Phase 2 Results for Once-Weekly TransCon hGH in Turner Syndrome
28d ago
6K
ASND
Ascendis Pharma Reports Two-Year Data Showing Sustained Benefits of YUVIWEL in Children With Achondroplasia
Premium
Company Announcements
Ascendis Pharma Reports Two-Year Data Showing Sustained Benefits of YUVIWEL in Children With Achondroplasia
29d ago
6K
ASND
More ASND News >

ASND News on the Web

Evercore ISI Keeps Their Buy Rating on Ascendis Pharma (ASND)
TipRanks News
Bullish
Why Ascendis Pharma Stock Is Suddenly Surging
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND) and Regeneron (REGN)
TipRanks News
Bullish
Wedbush Reaffirms Their Buy Rating on Ascendis Pharma (ASND)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND) and Cytokinetics (CYTK)
TipRanks News
Neutral
Ascendis Pharma Reports Strong Week 52 COACH Trial Data for TransCon CNP and hGH Combo in Achondroplasia
TipRanks News
Bullish
Ascendis Pharma to Replace ADSs With Direct Ordinary Share Listing on Nasdaq
TipRanks News
Neutral
Ascendis Pharma to list ordinary shares directly on Nasdaq
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
ASND
Sector Average
Media Buzz
This Week9 articles
Weekly Average5.75 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ASND’s Media Buzz Sentiment?
9 articles about ASND were published this week. In an average week, 5.75 articles are published.
    What is ASND’s weekly average amount of articles?
    In an average week, 5.75 articles about ASND are published.
      What is ASND’s News Sentiment?
      100% of articles about ASND were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        TXTMProText Mobility
        ALLOAllogene Therapeutics
        REPLReplimune Group
        IVVDInvivyd
        SLPSimulations Plus
        Showing the stocks with the most bullish news sentiment over the past week